Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 2, 2026.
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
Counts cover the 29 most recent Form 4 filings Tradune holds for ROIV (filed Jul 21 – Oct 2, 2026); the score below covers only the trailing 90 days (0 buys, 16 sells). No completed check of ROIV's Form 4 list on SEC EDGAR is on record yet; the latest ROIV filing Tradune holds was filed Oct 2, 2026. This is not guaranteed to be the complete record — see ROIV's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 26 filings Tradune holds for ROIV filed Jul 29 – Oct 2, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
Open-market purchases and sales by insider
Insider
Buys
Sells
Shares bought
Shares sold
Value
Mayukh SukhatmePresident & CIO
0
7
—
1,000,000
−$36,521,215
Eric VenkerPresident & Immunovant CEO
0
4
—
600,000
−$21,467,393
Meghan FitzgeraldDirector
0
3
—
25,112
−$1,001,152
Epperly Melissa BDirector
0
2
—
4,938
−$196,230
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 16 sell tx
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying.
“Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ROIV
No open-market insider purchases (Form 4 code P) were reported for ROIV between Jul 21, 2026 and Oct 2, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
Eric Venker President & Immunovant CEO · filed Oct 2, 2026 ·
SEC ↗
Transaction
Shares
Price
Held after
Change†
Date
Option exercise
200,000
$3.85
1,799,154
+13%
Sep 30, 2026
Option exerciseStock Option (Right to Buy)
200,000
—
—
—
Sep 30, 2026
Open-market sale10b5-1 box checked
200,000
$36.62
1,599,154
−11%
Sep 30, 2026
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
Listing the 25 most recent of 29 Form 4 filings held for ROIV; the 4 older filings (filed Jul 21 – Jul 29, 2026) are counted above but not listed here — see ROIV's full Form 4 filing history on SEC EDGAR.
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ROIV's (Oct 2, 2026).
How many insiders bought ROIV stock in these Form 4 filings?
No open-market purchases (Form 4 code P) of ROIV shares were reported by Roivant Sciences Ltd insiders between Jul 21, 2026 and Oct 2, 2026. The 29 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.
Who filed the most recent Form 4 for ROIV?
The most recent Form 4 on this page was filed by Frank Torti (President and Vant Chair) on Oct 2, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ROIV insider sale shown?
The largest open-market sale among the filings shown was 284,707 ROIV shares at $36.25 (about $10,320,629) by Mayukh Sukhatme (President & CIO) on Aug 17, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ROIV — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.